Community/Retail

This month's featured products include the pneumococcal 20-valent conjugate vaccine, semaglutide injection, and more.

This week’s recommendation by the Biden administration for booster shots to combat COVID-19 is a call to action for pharmacists to get ready for the upcoming flurry of activity.

Expanding services and revenues for pharmacies while improving public health and reducing stress on parents and others in the health care system is a win-win-win situation.

The investigators concluded that a definite statement on risk or management recommendations cannot be made based on currently published data.

The pharmaceutical market is massive, clocking in at more than $1.2 trillion in 2020, with an anticipated growth of nearly $22 billion dollars expected in 2021. Examining which drug makes up the most of that revenue, one name pulls far away from the competition.

Study indicates that the genetics affecting aggression in children with attention-deficit hyperactivity disorder and disruptive behavior disorders are the same as genetics underlying aggression in the general population.

But state-to-state communications and inconsistencies related to licensing present legal issues.

The lower the glomerular filtration rate, the lower the stage, the worse kidney disease is.

Whereas traditional vaccines have used live or inactivated pathogens to elicit an immune response, mRNA is responsible for cellular processes, building structures, and more.

How would you answer these patients' questions?

The investigators analyzed a panel of antibodies generated in response to the Pfizer COVID-19 vaccine and found that delta was unable to evade all but 1 of the antibodies tested.

In clinical trials, empagliflozin significantly reduced the relative risk of the primary composite endpoint of time to cardiovascular death or hospitalization for heart failure by 25%.

CMS reported that 3.3 million more Medicare Part D beneficiaries with complex health needs than expected between 2013-2018 received a comprehensive medication review as a part of medication therapy management

According to the investigators, both trials demonstrated an overall well-tolerated safety profile for brolucizumab.

According to Fenn, these numbers are significant when considering the types of errors that are likely to occur in sleep-deprived operators, such as surgeons or police officers, and the 4% decrease in errors could potentially save lives.

Severe persistent asthma is the worse type of asthma.

Expectations for pharmacists related to drug utilization reviews lead to examination of woman's death.

Widespread COVID-19 booster shot administration is pending FDA approval and recommendation by the Advisory Committee on Immunization Practices.

New roles and responsibilities can be passed to pharmacy technicians in order to free up pharmacists’ time, which enables them to be more engaged with their patients and provide more direct patient care.

What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.

Amesh Adalja, MD, FIDSA, FACP, FACEP, said that the efficacy of COVID-19 booster vaccines against variants of concern is still relatively unknown, although administering the third shots does increase antibodies as expected.

Ten quiz questions to assess your knowledge on common dyslipidemia treatments.

Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.

Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.

COVID-19 vaccination opportunities will likely be present for years to come.

The FDA has approved Qelbree (viloxazine extended-release capsules; Supernus Pharmaceuticals, Inc) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years.

Alembic Pharmaceuticals, Inc in Bridgewater, NJ is a subsidiary of Alembic Pharmaceuticals Ltd., the oldest pharmaceutical company in India, employing more than 12,000 people.